drugset / Trial / NCT02716519

Use of Santyl Within an Accountable Care Organization

NCT02716519

Phase 4 Withdrawn Smith & Nephew, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is designed to assess the comparative effectiveness of SANTYL® versus standard of care in the treatment of pressure ulcers and diabetic foot ulcers within the continuum of care of an ACO. After meeting study criteria, participants will be randomly assigned to apply Santyl or standard care to their pressure ulcer or diabetic foot ulcer for up to 6 weeks. Participants will be followed for one year from the date of randomization to assess ulcer status and ulcer complications.

Timeline

Start
2016-08
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Collagenase Clostridium Histolyticum Protein / enzyme biologic Topical